Live from the NIH registry
Studies recruiting near Worcester right now
Top 25 of 269 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
Myasthenia Gravis Foundation of America Global MG Patient Registry
Myasthaenia Gravis, Myasthenia
N/A
Observational 3,800 participants sought
Myasthenia Gravis Foundation of America — Westborough, Massachusetts (9.8 mi)
· Sponsor: Myasthenia Gravis Foundation of America
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Non-segmental Vitiligo
Phase 2
Interventional 45 participants sought
U Mass Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: SWOG Cancer Research Network
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Worcester, Massachusetts (0.6 mi)
· Sponsor: AstraZeneca
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
University of Massachusetts Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Eli Lilly and Company
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
UMass Memorial Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: Joseph Broderick, MD
ARISe at UMass Chan
Vaccination, Vaccination Promotion
N/A
Interventional 700 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma
PTSD, Alcohol; Use, Problem
N/A
Interventional 144 participants sought
University of Massachusetts Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
Promoting Improved Functioning Among People Experiencing Stressful Situations
Acute Stress Reaction
N/A
Interventional 450 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of North Carolina, Chapel Hill
An Evaluation of the Effect of the Erchonia FX-405 Laser as an Adjunctive Treatment of Periodontitis
Periodontal Diseases, Periodontitis
N/A
Interventional 70 participants sought
Acton Dental Associates — Acton, Massachusetts (24.2 mi)
· Sponsor: Erchonia Corporation
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Phase 3
Interventional 160 participants sought
UMass Memorial Healthcare — Worcester, Massachusetts (0.6 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 300 participants sought
University of Massachusetts — Worcester, Massachusetts (0.6 mi)
· Sponsor: Surgimab
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Phase 3
Interventional 200 participants sought
New England Regional Headache Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: Pfizer
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Insomnia Disorder
Phase 3
Interventional 420 participants sought
Vanda Investigational Site — Worcester, Massachusetts (0.6 mi)
· Sponsor: Vanda Pharmaceuticals
Retropubic Hydrodissection and Trocar-induced Bladder Perforation During Retropubic Midurethral Slings
Bladder Perforation, Retropubic Midurethral Sling
N/A
Interventional 300 participants sought
University of Massachusetts Memorial Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
Testimonials and Navigation in Rheumatology
Rheumatologic Disease, Autoimmune Diseases
N/A
Interventional 1,170 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study
Cytomegalovirus Infections
N/A
Observational 100 participants sought
UMass Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigationa Site 7104 — Milford, Massachusetts (17.4 mi)
· Sponsor: Galderma R&D
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
Systemic Sclerosis
Phase 3
Interventional 92 participants sought
Local Institution - 0084 — Worcester, Massachusetts (0.6 mi)
· Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Breast Cancer, Triple Negative Breast Cancer
Phase 2
Interventional 110 participants sought
DFCI @ Milford Regional Hospital — Milford, Massachusetts (17.4 mi)
· Sponsor: Dana-Farber Cancer Institute
Asthma Link Effectiveness Trial
Childhood Asthma
N/A
Interventional 350 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
Validation of Chlamydia Diagnostic Codes in TriNetX US EHR Data
Chlamydial Infections
N/A
Observational 533,000 participants sought
University of Massachusetts Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Sanofi